Role of Traditional Chinese Medicine in the Management of Viral Pneumonia

Overview

Journal Front Pharmacol

Date 2020 Nov 16

PMID 33192523

Citations 18

Authors

Shengyan Xi

Yunhong Li

Lifeng Yue

Yuewen Gong

Linchao Qian

Tengxiao Liang

Yongan Ye

Affiliations

Soon will be listed here.

Abstract

Viral pneumonia is one kind of acute respiratory tract infection caused by the virus. There have been many outbreaks of viral pneumonia with high contagiousness and mortality both in China and abroad, such as the great influenza in 1918, the severe acute respiratory syndrome (SARS) coronavirus in 2003, the Influenza A (H1N1) virus in 2009, and the Middle East Respiratory Syndrome coronavirus (MERS-CoV) in 2012 and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019. These outbreaks and/or pandemic have significant impact on human life, social behaviors, and economic development. Moreover, no specific drug has been developed for these viruses. Traditional Chinese medicine (TCM) plays an important role in the treatment of viral pneumonia during these outbreaks especially in SARS and SARS-CoV-2 because studies suggest that TCM formulations may target several aspects of the disease and may have lesser side effects than manufactured pharmaceuticals. In recent years, a lot of clinicians and researchers have made a series of in-depth explorations and investigations on the treatment of viral pneumonia with TCM, which have understood TCM therapeutic mechanisms more specifically and clearly. But critical analysis of this research in addition to further studies are needed to assess the potential of TCM in the treatment of viral pneumonia.

Citing Articles

Antiviral treatment for viral pneumonia: current drugs and natural compounds.

Zhang H, Ge C, Fisher D, Hien N, Musabaev E, Pronyuk K Virol J. 2025; 22(1):62.

PMID: 40050867 PMC: 11887211. DOI: 10.1186/s12985-025-02666-1.

T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection.

Liu S, Lin M, Zhou X Vaccines (Basel). 2025; 13(1).

PMID: 39852849 PMC: 11769387. DOI: 10.3390/vaccines13010070.

Fei-Yan-Qing-Hua decoction attenuates influenza virus infection by enhancing host antiviral response through microbiota-derived acetate.

Dou B, Wu X, He Y, Xu G, Zhang H, Huang Q Front Pharmacol. 2024; 15:1446749.

PMID: 39449967 PMC: 11499185. DOI: 10.3389/fphar.2024.1446749.

Tanreqing Injection Inhibits Activation of NLRP3 Inflammasome in Macrophages Infected with Influenza A Virus by Promoting Mitophagy.

Liu T, Hao Y, Mao Q, Zhou N, Liu M, Wu J Chin J Integr Med. 2024; 31(1):19-27.

PMID: 38910190 DOI: 10.1007/s11655-024-3905-3.

Therapeutic effect of Yinhuapinggan granules mediated through the intestinal flora in mice infected with the H1N1 influenza virus.

Yang C, Chen J, Zhou H, Zeng D, Wan H, Yang J Front Microbiol. 2024; 15:1394304.

PMID: 38741735 PMC: 11089240. DOI: 10.3389/fmicb.2024.1394304.

References

Liu J, Manheimer E, Shi Y . [Systematic review and meta-analysis on the integrative traditional Chinese and Western medicine in treating SARS]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006; 25(12):1082-8. View

Liu J, Zu M, Chen K, Gao L, Min H, Zhuo W . Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines. BMC Complement Altern Med. 2018; 18(1):102. PMC: 5859433. DOI: 10.1186/s12906-018-2173-1. View

Wan Q, Wang H, Han X, Lin Y, Yang Y, Gu L . Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza A virus. Biomed Rep. 2014; 2(3):437-441. PMC: 3990210. DOI: 10.3892/br.2014.253. View

Luo W, Wang J, Liu C, Huang C . [Effect of electroacupuncture stimulation of "Feishu" (BL 13) on lung index, serum and lung IL-10 and TNF-alpha levels in mice with viral pneumonia]. Zhen Ci Yan Jiu. 2014; 39(4):293-7. View

Zhuang M, Jiang H, Suzuki Y, Li X, Xiao P, Tanaka T . Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 2009; 82(1):73-81. PMC: 7114128. DOI: 10.1016/j.antiviral.2009.02.001. View

Zhuang W, Fan Z, Chu Y, Wang H, Yang Y, Wu L . Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China. Front Pharmacol. 2020; 11:1066. PMC: 7396557. DOI: 10.3389/fphar.2020.01066. View

Xin S, Cheng X, Zhu B, Liao X, Yang F, Song L . Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Biomed Pharmacother. 2020; 129:110500. PMC: 7342031. DOI: 10.1016/j.biopha.2020.110500. View

Li H, Yan D, Wang J, Wang J, Bei Z, Wei L . [Biological evaluation of Radix Isatidis based on neuraminidase activity assay]. Yao Xue Xue Bao. 2009; 44(2):162-6. View

Mantani N, Imanishi N, Kawamata H, Terasawa K, Ochiai H . Inhibitory effect of (+)-catechin on the growth of influenza A/PR/8 virus in MDCK cells. Planta Med. 2001; 67(3):240-3. DOI: 10.1055/s-2001-12009. View

10.

Woolhouse M, Brierley L, McCaffery C, Lycett S . Assessing the Epidemic Potential of RNA and DNA Viruses. Emerg Infect Dis. 2016; 22(12):2037-2044. PMC: 5189130. DOI: 10.3201/eid2212.160123. View

11.

Liu M, Gao Y, Yuan Y, Yang K, Shi S, Zhang J . Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 2020; 158:104896. PMC: 7211759. DOI: 10.1016/j.phrs.2020.104896. View

12.

Sornpet B, Potha T, Tragoolpua Y, Pringproa K . Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus. Asian Pac J Trop Med. 2017; 10(9):871-876. DOI: 10.1016/j.apjtm.2017.08.010. View

13.

Jain S . Epidemiology of Viral Pneumonia. Clin Chest Med. 2017; 38(1):1-9. PMC: 7115731. DOI: 10.1016/j.ccm.2016.11.012. View

14.

Yan Y, Fu Y, Wu S, Qin H, Zhen X, Song B . Anti-influenza activity of berberine improves prognosis by reducing viral replication in mice. Phytother Res. 2018; 32(12):2560-2567. DOI: 10.1002/ptr.6196. View

15.

Ling L, Lu Y, Zhang Y, Zhu H, Tu P, Li H . Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling. Phytomedicine. 2020; 67:153150. DOI: 10.1016/j.phymed.2019.153150. View

16.

Ding Y, Zeng L, Li R, Chen Q, Zhou B, Chen Q . The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med. 2017; 17(1):130. PMC: 5324200. DOI: 10.1186/s12906-017-1585-7. View

17.

Zhang R, Jiao Q, Wang B . [Controlled clinical study on 49 patients of SARS treated by integrative Chinese and Western medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003; 23(9):654-7. View

18.

Geng Z, Li Y, Cui Q, DU R, Tian J . Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection. Chin J Nat Med. 2019; 17(9):650-662. PMC: 7128581. DOI: 10.1016/S1875-5364(19)30079-2. View

19.

Wen C, Shyur L, Jan J, Liang P, Kuo C, Arulselvan P . Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J Tradit Complement Med. 2014; 1(1):41-50. PMC: 3942999. DOI: 10.1016/s2225-4110(16)30055-4. View

20.

Casadevall A, Pirofski L . Microbiology: Ditch the term pathogen. Nature. 2014; 516(7530):165-6. DOI: 10.1038/516165a. View